Life Science Webinars

  1. How to Ensure Biosafety Of Novel Viral Therapies

    Novel viral therapies are emerging and gaining more interest after recent regulatory approval of CAR-T and AAV based gene therapies. While no viral contamination has been reported so far for these therapies, it is important to learn from historical experience and leverage improved manufacturing and testing methods to increase their safety. This would help avoid product supply and patient treatment disruptions as well as protect the company’s business and reputation. In this webinar we will highlight the biosafety challenges associated with the manufacture of viral vectors and how a holistic risk mitigation approach can reduce contamination events.

  2. Facility Intensification And Cost Reduction Using An Integrated Buffer Delivery Platform

    Outsourcing or implementing a streamlined buffer preparation and management systems allows biomanufacturers to considerably reduce floor usage, labor and costs. In this webinar, we will explore the benefits of an Integrated Buffer Delivery Platform.

  3. Implementing A Fully Single-Use, Integrated mAb Biosimilars Purification Platform For Next Generation Manufacturing

    Within the biopharmaceutical industry, there is a significant shift toward higher productivity processes resulting in improved economics without compromising robustness. Therefore, integrated continuous production technologies are of greatest interest. 

  4. Smarter Development Of Chromatography Processes – Reducing Timelines And Improving Outcomes

    Time to experiment, time to clinic, and time to market is becoming even more important for developers and manufacturers of biopharmaceuticals. At the same time, the amount of data enclosed in biologic license applications are more comprehensive to avoid extended review. In this webinar we will review three fields that enable reduced timelines and improved outcomes of process development activities.

  5. CHT Column Packing Is Easier Than You Think!

    This webinar details best practices and guidelines for packing CHT Ceramic Hydroxyapatite Media at process scale. CHT is an easy-to-use mixed-mode chromatography media which offers cation exchange and affinity interactions. Unlike other chromatography media, CHT is both the ligand and the support matrix, and is used for the purification of numerous types of biomolecules. It is considered the gold standard for aggregate removal.

  6. Ceramic Hydroxyapatite Chromatography Media – How To Start

    Ceramic Hydroxyapatite XT, is a calcium affinity cation exchange chromatography media. It is used for the purification of numerous types of biomolecules and provides single-step clearance of impurities and aggregates for monoclonal antibody purification. CHT XT is an easy-to-use mixed-mode chromatography media. Unlike other chromatography media it is both the ligand and the support matrix. 

  7. AEX Mixed-Mode Chromatography Resin For High Selectivity And Recovery

    Dr. Xuemei He introduces the features of Nuvia aPrime 4A resin that has been optimized to facilitate selective and reversible binding of molecules for high purity and recovery over traditional chromatography resins. Case studies demonstrate the purification of biomolecules with acidic and basic isolectric points and highlight these advantages.

  8. Nuvia HP-Q A New High Performance AEX Resin

    Nuvia HP-Q is our newest strong anion exchange resin. It provides both high binding capacity and high recovery, even at high flow rates. A rigid bead with large pores and optimized surface extenders, this resin was designed for large biomolecule purification. Dr. Jiali Liao will present case studies and design features to meet manufacturing demands.

  9. Process Impurities: Don’t Let PEI Or HCP Derail Your Biotherapy

    This presentation addresses product characterization strategies to de-risk the manufacturing of mAbs and cell and gene therapies. It also covers detection and characterization of host cell proteins (a factor in mAb therapies and cell and gene therapies), and polyethylenimine used in cell and gene therapies.

  10. Capture OTC Market Share For Geriatric And Pediatric Patients

    This webinar discusses how the unique properties of gelatin have been used to develop chewable softgel formulations for the pediatric and geriatric patient populations.